A deep learning framework combines convolutional and bidirectional recurrent networks to improve protein function prediction from genomic ...

UPSIDE Foods is building "a new vertical business in the life sciences industry with an initial focus on cell culture media.” ...

NEW YORK – Boston Children's Hospital has granted a worldwide license for an investigational gene therapy for sickle cell disease and beta thalassemia to Caring Cross, the nonprofit announced this ...

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and ...

SK Bioscience on Monday completed its relocation to its new headquarters in Incheon, as the company seeks to transform its ...

Kalaburagi: In a major step towards controlling rabies, the Karnataka Veterinary, Animal and Fisheries Sciences University ...

Samsung Biologics expands Korea CRDMO lead with MCB and vector services Samsung Biologics widens CRDMO edge with new MCB and ...

Open heart surgery is a common but invasive procedure. Surgeons have tested an unconventional way to perform coronary artery bypass without cracking the chest.

Oxford, major contract manufacturer to cell and gene therapy companies, has already rejected multiple, unsolicited ...

About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...